Reduced glutathione as a physiological co-activator in the activation of peptidylarginine deiminase

Arthritis Research and Therapy

Volumn 18, Issue 1, 2016, Pages

  Damgaard, Dres ^a,b   Bjørn, Mads Emil ^a,c   Steffensen, Maria A ^a   Pruijn, Ger J M ^d   Nielsen, Claus H ^a,b  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c ROSKILDE HOSPITAL   (Denmark)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Citrullination; Peptidylarginine deiminase; Reduced glutathione; Rheumatoid arthritis; Synovial fluid

Indexed keywords

2 ACETYLAMINO 3 [4 (2 ACETYLAMINO 2 CARBOXYETHYLSULFANYLTHIOCARBONYLAMINO)PHENYLTHIOCARBAMOYLSULFANYL]PROPIONIC ACID; FIBRINOGEN; GLUTATHIONE; OXIDOREDUCTASE INHIBITOR; PEPTIDYLARGININE DEIMINASE 2; PEPTIDYLARGININE DEIMINASE 4; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN ARGININE DEIMINASE; UNCLASSIFIED DRUG; CITRULLINE; HYDROLASE; PROTEIN-ARGININE DEIMINASE;

ARTICLE; CATALYSIS; CITRULLINATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; LEUKOCYTE; MONONUCLEAR CELL; PROTEIN METABOLISM; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; METABOLISM; PHYSIOLOGY;

ARTHRITIS, RHEUMATOID; CITRULLINE; ENZYME ACTIVATION; GLUTATHIONE; HUMANS; HYDROLASES; SYNOVIAL FLUID;

EID: 84965036958     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/s13075-016-1000-7     Document Type: Article

References (36)

1. Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003;25:1106-18.
2. van Venrooij WJ, van Beers JJ, Pruijn GJ. Anti-CCP antibodies: the past, the present and the future. Nat Rev Rheumatol. 2011;7:391-8.
3. Pruijn GJ. Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis. Front Immunol. 2015;6:192.
4. Moscarello MA, Mastronardi FG, Wood DD. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem Res. 2007;32:251-6.
5. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res. 2005;80:120-8.
6. Gyorgy B, Toth E, Tarcsa E, Falus A, Buzas EI. Citrullination: a posttranslational modification in health and disease. Int J Biochem Cell Biol. 2006;38:1662-77.
7. Herrera-Esparza R, Rodriguez-Rodriguez M, Perez-Perez ME, Badillo-Soto MA, Torres-Del-Muro F, Bollain YGJ, et al. Posttranslational protein modification in the salivary glands of Sjogren's syndrome patients. Autoimmune Dis. 2013;2013:548064.
8. Rondas D, Crevecoeur I, D'Hertog W, Ferreira GB, Staes A, Garg AD, et al. Citrullinated glucose-regulated protein 78 is an autoantigen in type 1 diabetes. Diabetes. 2015;64:573-86.
9. Ruiz-Esquide V, Gomara MJ, Peinado VI, Gomez Puerta JA, Barbera JA, Canete JD, et al. Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease? Clin Rheumatol. 2012;31:1047-1050.
10. Arita K, Hashimoto H, Shimizu T, Nakashima K, Yamada M, Sato M. Structural basis for Ca(2+)-induced activation of human PAD4. Nat Struct Mol Biol. 2004;11:777-83.
11. Dreyton CJ, Knuckley B, Jones JE, Lewallen DM, Thompson PR. Mechanistic studies of protein arginine deiminase 2: evidence for a substrate-assisted mechanism. Biochemistry. 2014;53:4426-33.
12. Damgaard D, Senolt L, Nielsen M, Pruijn G, Nielsen CH. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Arthritis Res Ther. 2014;16:498.
13. De RL, Nicholas AP, Cantaert T, Kruithof E, Echols JD, Vandekerckhove B, et al. Synovial intracellular citrullinated proteins colocalizing with peptidyl arginine deiminase as pathophysiologically relevant antigenic determinants of rheumatoid arthritis-specific humoral autoimmunity. Arthritis Rheum. 2005;52:2323-30.
14. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem. 2007;113:234-58.
15. Dixon BM, Heath SH, Kim R, Suh JH, Hagen TM. Assessment of endoplasmic reticulum glutathione redox status is confounded by extensive ex vivo oxidation. Antioxid Redox Signal. 2008;10:963-72.
16. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med. 1999;27:922-35.
17. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002;348:93-112.
18. Sredzinska K, Galicka A, Porowska H, Sredzinski L, Porowski T, Popko J. Glutathione reductase activity correlates with concentration of extracellular matrix degradation products in synovial fluid from patients with joint diseases. Acta Biochim Pol. 2009;56:635-40.
19. Garcia-Gonzalez A, Gaxiola-Robles R, Zenteno-Savin T. Oxidative stress in patients with rheumatoid arthritis. Rev Invest Clin. 2015;67:46-53.
20. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-24.
21. Raijmakers R, Zendman AJ, Egberts WV, Vossenaar ER, Raats J, Soede-Huijbregts C, et al. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol. 2007;367:1118-29.
22. Damgaard D, Palarasah Y, Skjodt K, Catrina AI, Hensen SM, Pruijn GJ, et al. Generation of monoclonal antibodies against peptidylarginine deiminase 2 (PAD2) and development of a PAD2-specific enzyme-linked immunosorbent assay. J Immunol Methods. 2014;405:15-22.
23. Damgaard D, Senolt L, Nielsen CH. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers. Rheumatology (Oxford). 2016;55:918-927.
24. Seefeldt T, Zhao Y, Chen W, Raza AS, Carlson L, Herman J, et al. Characterization of a novel dithiocarbamate glutathione reductase inhibitor and its use as a tool to modulate intracellular glutathione. J Biol Chem. 2009;284:2729-37.
25. Zendman AJ, Raijmakers R, Nijenhuis S, Vossenaar ER, Tillaart M, Chirivi RG, et al. ABAP: antibody-based assay for peptidylarginine deiminase activity. Anal Biochem. 2007;369:232-40.
26. Blachere NE, Parveen S, Fak J, Frank MO, Orange DE. Inflammatory but not apoptotic death of granulocytes citrullinates fibrinogen. Arthritis Res Ther. 2015;17:369.
27. Spengler J, Lugonja B, Jimmy YA, Zubarev RA, Creese AJ, Pearson MJ, et al. Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid. Arthritis Rheumatol. 2015;67:3135-45.
28. Takizawa Y, Suzuki A, Sawada T, Ohsaka M, Inoue T, Yamada R, et al. Citrullinated fibrinogen detected as a soluble citrullinated autoantigen in rheumatoid arthritis synovial fluids. Ann Rheum Dis. 2006;65:1013-20.
29. van Beers JJ, Schwarte CM, Stammen-Vogelzangs J, Oosterink E, Bozic B, Pruijn GJ. The rheumatoid arthritis synovial fluid citrullinome reveals novel citrullinated epitopes in apolipoprotein E, myeloid nuclear differentiation antigen, and beta-actin. Arthritis Rheum. 2013;65:69-80.
30. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, et al. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science. 2004;306:279-83.
31. Li P, Yao H, Zhang Z, Li M, Luo Y, Thompson PR, et al. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol. 2008;28:4745-58.
32. Wang S, Wang Y. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis. Biochim Biophys Acta. 2013;1829:1126-35.
33. Markovic J, Borras C, Ortega A, Sastre J, Vina J, Pallardo FV. Glutathione is recruited into the nucleus in early phases of cell proliferation. J Biol Chem. 2007;282:20416-24.
34. Diaz VP, Wolff T, Markovic J, Pallardo FV, Foyer CH. A nuclear glutathione cycle within the cell cycle. Biochem J. 2010;431:169-78.
35. Pallardo FV, Markovic J, Garcia JL, Vina J. Role of nuclear glutathione as a key regulator of cell proliferation. Mol Aspects Med. 2009;30:77-85.
36. Yoshida S, Katoh T, Tetsuka T, Uno K, Matsui N, Okamoto T. Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-alpha-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol. 1999;163:351-8.